The site is undergoing maintenance on
Thursday, September 10, 6:00 pm through Friday, September 11, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 6:00 pm through Friday, September 11, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 6:00 pm through Friday, September 11, 2:00 am (CEST), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Two-color flow cytometric analysis of Ikaros expression on human peripheral blood lymphocytes. Human peripheral blood mononuclear cells were stained with PE Mouse Anti-Human CD3 antibody (Cat. No. 555333/561808/561809). The cells were fixed and permeabilized using the BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725). The cells were then stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557732; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human Ikaros antibody (Cat. No. 564868; Right Panel). Two-color flow cytometric contour plots showing the correlated expression patterns of Ikaros (or Ig Isotype control staining) versus CD3 were generated for gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ikaros expression on human peripheral blood lymphocytes. Human peripheral blood mononuclear cells were stained with PE Mouse Anti-Human CD3 antibody (Cat. No. 555333/561808/561809). The cells were fixed and permeabilized using the BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725). The cells were then stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557732; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human Ikaros antibody (Cat. No. 564868; Right Panel). Two-color flow cytometric contour plots showing the correlated expression patterns of Ikaros (or Ig Isotype control staining) versus CD3 were generated for gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ikaros expression on human peripheral blood lymphocytes. Human peripheral blood mononuclear cells were stained with PE Mouse Anti-Human CD3 antibody (Cat. No. 555333/561808/561809). The cells were fixed and permeabilized using the BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725). The cells were then stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557732; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human Ikaros antibody (Cat. No. 564868; Right Panel). Two-color flow cytometric contour plots showing the correlated expression patterns of Ikaros (or Ig Isotype control staining) versus CD3 were generated for gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ikaros expression on human peripheral blood lymphocytes. Human peripheral blood mononuclear cells were stained with PE Mouse Anti-Human CD3 antibody (Cat. No. 555333/561808/561809). The cells were fixed and permeabilized using the BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725). The cells were then stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557732; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human Ikaros antibody (Cat. No. 564868; Right Panel). Two-color flow cytometric contour plots showing the correlated expression patterns of Ikaros (or Ig Isotype control staining) versus CD3 were generated for gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ikaros expression on human peripheral blood lymphocytes. Human peripheral blood mononuclear cells were stained with PE Mouse Anti-Human CD3 antibody (Cat. No. 555333/561808/561809). The cells were fixed and permeabilized using the BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725). The cells were then stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557732; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human Ikaros antibody (Cat. No. 564868; Right Panel). Two-color flow cytometric contour plots showing the correlated expression patterns of Ikaros (or Ig Isotype control staining) versus CD3 were generated for gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ikaros expression on human peripheral blood lymphocytes. Human peripheral blood mononuclear cells were stained with PE Mouse Anti-Human CD3 antibody (Cat. No. 555333/561808/561809). The cells were fixed and permeabilized using the BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725). The cells were then stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557732; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human Ikaros antibody (Cat. No. 564868; Right Panel). Two-color flow cytometric contour plots showing the correlated expression patterns of Ikaros (or Ig Isotype control staining) versus CD3 were generated for gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ikaros expression on human peripheral blood lymphocytes. Human peripheral blood mononuclear cells were stained with PE Mouse Anti-Human CD3 antibody (Cat. No. 555333/561808/561809). The cells were fixed and permeabilized using the BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725). The cells were then stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557732; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human Ikaros antibody (Cat. No. 564868; Right Panel). Two-color flow cytometric contour plots showing the correlated expression patterns of Ikaros (or Ig Isotype control staining) versus CD3 were generated for gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ikaros expression on human peripheral blood lymphocytes. Human peripheral blood mononuclear cells were stained with PE Mouse Anti-Human CD3 antibody (Cat. No. 555333/561808/561809). The cells were fixed and permeabilized using the BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725). The cells were then stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557732; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human Ikaros antibody (Cat. No. 564868; Right Panel). Two-color flow cytometric contour plots showing the correlated expression patterns of Ikaros (or Ig Isotype control staining) versus CD3 were generated for gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ikaros expression on human peripheral blood lymphocytes. Human peripheral blood mononuclear cells were stained with PE Mouse Anti-Human CD3 antibody (Cat. No. 555333/561808/561809). The cells were fixed and permeabilized using the BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725). The cells were then stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557732; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human Ikaros antibody (Cat. No. 564868; Right Panel). Two-color flow cytometric contour plots showing the correlated expression patterns of Ikaros (or Ig Isotype control staining) versus CD3 were generated for gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ikaros expression on human peripheral blood lymphocytes. Human peripheral blood mononuclear cells were stained with PE Mouse Anti-Human CD3 antibody (Cat. No. 555333/561808/561809). The cells were fixed and permeabilized using the BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725). The cells were then stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557732; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human Ikaros antibody (Cat. No. 564868; Right Panel). Two-color flow cytometric contour plots showing the correlated expression patterns of Ikaros (or Ig Isotype control staining) versus CD3 were generated for gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ikaros expression on human peripheral blood lymphocytes. Human peripheral blood mononuclear cells were stained with PE Mouse Anti-Human CD3 antibody (Cat. No. 555333/561808/561809). The cells were fixed and permeabilized using the BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725). The cells were then stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557732; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human Ikaros antibody (Cat. No. 564868; Right Panel). Two-color flow cytometric contour plots showing the correlated expression patterns of Ikaros (or Ig Isotype control staining) versus CD3 were generated for gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ikaros expression on human peripheral blood lymphocytes. Human peripheral blood mononuclear cells were stained with PE Mouse Anti-Human CD3 antibody (Cat. No. 555333/561808/561809). The cells were fixed and permeabilized using the BD Pharmingen™ Transcription Factor Buffer Set (Cat. No. 562574/562725). The cells were then stained with either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557732; Left Panel) or Alexa Fluor® 647 Mouse Anti-Human Ikaros antibody (Cat. No. 564868; Right Panel). Two-color flow cytometric contour plots showing the correlated expression patterns of Ikaros (or Ig Isotype control staining) versus CD3 were generated for gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The R32-1149 monoclonal antibody specifically binds to Ikaros, which is encoded by IKZF1 (IKAROS family zinc finger 1). Ikaros is also known as Lymphoid transcription factor LyF-1 (LYF1) and ZNFN1A1 [Zinc finger protein, subfamily 1A, 1 (Ikaros)]. Ikaros belongs to the IKAROS family of zinc-finger transcription factors. This DNA-binding transcription factor forms homodimers and heterodimers with other IKAROS family members. It is involved in the development of lymphoid tissues and remains abundantly expressed in the thymus and by cells within peripheral lymphoid tissues. Ikaros functions in the maturation, differentiation, and homeostasis of various hematopoietic cells including T lymphocytes, B cells, NK cells, and neutrophils. Ikaros regulates the expression of a number of genes including various genes expressed during early stages of B- and T-cell development. Several alternatively-spliced human Ikaros isoforms have been described. Abnormal expression of different Ikaros isoforms has been associated with hematologic malignancies. Flow cytometric analysis of 293F cells transfected with members of the IKAROS family has demonstrated that clone R32-1149 is negative on Helios, Aiolos, and Eos transfectants.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.